IRIS
GROSSI, Laurino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.520
EU - Europa 4.313
AS - Asia 2.035
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 6
AF - Africa 3
OC - Oceania 1
Totale 10.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.503
CN - Cina 965
UA - Ucraina 814
IT - Italia 712
IE - Irlanda 706
TR - Turchia 560
SE - Svezia 554
GB - Regno Unito 476
FR - Francia 390
IN - India 344
DE - Germania 243
FI - Finlandia 154
RU - Federazione Russa 125
SG - Singapore 104
AT - Austria 46
VN - Vietnam 36
PL - Polonia 35
EU - Europa 20
BE - Belgio 15
RO - Romania 15
MX - Messico 9
CA - Canada 8
GR - Grecia 6
IL - Israele 6
TW - Taiwan 5
CZ - Repubblica Ceca 4
ES - Italia 4
HK - Hong Kong 4
AL - Albania 3
CL - Cile 3
IR - Iran 3
KR - Corea 3
NL - Olanda 3
NO - Norvegia 3
AR - Argentina 2
CH - Svizzera 2
JP - Giappone 2
LU - Lussemburgo 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
ID - Indonesia 1
KH - Cambogia 1
MA - Marocco 1
MU - Mauritius 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.899
Salva come PNG Salva come JPEG
Città #
Jacksonville 943
Chandler 779
Dublin 698
Dearborn 468
Southend 378
Princeton 354
Nanjing 284
Izmir 272
Wilmington 254
Beijing 169
Cambridge 157
Ashburn 119
Woodbridge 119
Ann Arbor 115
Nanchang 93
Boardman 66
Singapore 62
Houston 61
Hebei 53
New York 51
Shenyang 48
Altamura 47
Kunming 45
Vienna 45
Tianjin 43
Rome 42
Jiaxing 40
Kraków 35
Chieti 29
Hefei 28
Hangzhou 27
Bologna 25
Norwalk 25
Los Angeles 24
Dong Ket 22
Düsseldorf 20
Jinan 20
Changsha 18
Orange 18
Bellante 15
Washington 15
Brussels 14
Grevenbroich 14
Guangzhou 14
Lanzhou 14
Vinh 14
Pescara 13
Fuzhou 11
Milan 11
Falls Church 10
Cepagatti 9
Changchun 9
Guadalajara 9
Ningbo 8
Seattle 8
Turin 8
Edinburgh 7
Helsinki 7
L'aquila 7
Mumbai 7
Varallo 7
Auburn Hills 5
Munich 5
Ripa Teatina 5
San Vito al Tagliamento 5
Villamagna 5
Hong Kong 4
Isernia 4
Redwood City 4
Senigallia 4
Siena 4
Simi Valley 4
Sulmona 4
Walnut 4
Xian 4
Zhengzhou 4
Amsterdam 3
Avezzano 3
Baotou 3
Brno 3
Cedar Knolls 3
Duncan 3
London 3
Marseille 3
Moscow 3
Mountain View 3
Palermo 3
Taizhou 3
Taranto 3
Teramo 3
Verona 3
Villafranca di Verona 3
Aprilia 2
Ardea 2
Armonk 2
Augusta 2
Bari 2
Brescia 2
Buenos Aires 2
Camden 2
Totale 6.456
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 352
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 133
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 105
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 104
Trasmissione di Helicobacter pylori in un modello murino 100
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 100
24-hour pancolonic motility using a portable electronic probe in healthy subjects 99
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 99
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 97
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 95
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 94
USO DI GOLIMUMAB COME SECONDA LINEA BIOLOGICA IN UN PAZIENTE CON RETTOCOLITE ULCEROSA 92
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 91
Ottimizzazione di vedolizumab in RCU con perdita di risposta a infliximab 91
Alterazioni non litiasiche del contenuto colecistico 88
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 88
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 87
ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 87
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 85
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 84
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 83
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 81
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 80
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 79
THERAPY-RELATED ADVERSE EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 79
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD). 79
Transmission of Helicobacter pylori in an animal model. 78
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 78
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 77
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 77
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 77
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 77
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 76
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 76
null 76
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 75
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 75
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 75
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 75
EFFICACY AND SAFETY OF LONG-TERM INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 75
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 75
THERAPY- RELATED ADVERS EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 75
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 75
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 74
RISPOSTA CLINICA E GUARIGIONE DELLA MUCOSA DOPO 4 ANNI DI TERAPIA CON INFLIXIMAB IN UN PAZIENTE CON MALATTIA DI CROHN ILEALE STEROIDO-RESISTENTE 74
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 74
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 74
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 74
Esophageal and gastric motility in patients with gastroesophageal reflux disease 73
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 73
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 73
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 73
LA MALDIGESTIONE 73
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 73
A “REAL LIVE” EXPERIENCE OF INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 73
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 73
Peppermint oil (Mintoil®) in the treatment or irritable bowel syndrome: a prospective double blind placebo controlled randomized trial. 72
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 72
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 71
EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN’S DISEASE 71
Increase of swallows before the onset of phase III of migrating motor complex in normal human subjects 70
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 69
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 68
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 68
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 67
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 67
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 67
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 67
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 67
Mouth to caecum transit time (MCTT) is accellerated after oral food antigen in patients with irritable bowel syndrome 67
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 67
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 67
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 66
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 66
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 66
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 66
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 66
EVALUATION OF FIBROSIS AND INTRAPARENCHIMAL BLOOD FLOW INCHIRROTIC PATIENTS, CHRONIC ACTIVE HEPATITIS AND NORMAL CONTROLS THROUGH FIBROSCAN AND ULTRASOUND ENHANCED CONTRAST MEDIA. 66
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 65
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 65
Detection of Helicobacter pylori in esophagus and saliva in humans 65
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 65
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 64
GASTRIC AND GALLBLADDER EMPTYING AFTER STANDARD SOLID MEAL IN NORMAL CONTROLS, PATIENTS WITH “MOTILITY-LIKE” DYSPEPSIA AND EFFECT OF DOMPERIDONE. 64
THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION 64
CLINICAL AND ECONOMIC IMPACT OF INFLIXIMAB ONE-HOUR INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY 64
Registrazione delle 24 ore della motilità del piloro in soggetti normali 63
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 63
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 63
LA MALATTIA DA REFLUSSO GASTROESOFAGEO 63
ON THE SPECIFICITY OF ALTERED MUSCLE FUNCTION IN EXPERIMENTAL COLITIS IN RATS 62
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 62
FPSE-HPLC-PDA METHOD FOR THE DETERMINATION OF INFLAMMATORY BOWEL DISEASE TREATMENT DRUGS IN WHOLE BLOOD, PLASMA AND URINE 62
Prolonged anal sphincter manometry in normal human subjects 61
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS PLAY AN INSIGNIFICANT ROLE IN GASTRO-ESOPHAGEAL REFLUX TO THE PROXIMAL ESOPHAGUS 61
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 61
Effect of cimetropium bromide on esophageal motility and transit in patients affected by primary achalasia. 60
EFFECT OF BACLOFEN ON ESOPHAGEAL MOTILITY AND TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS IN GERD PATIENTS: A 48-HOUR MANOMETRIC STUDY 60
LACTOSE MALABSORPTION (LM) AND IRRITABLE BOWEL SYNDROME (IBS): INCIDENCE AND EVALUATION OF SYMPTOMS 60
HIGH RESOLUTION MANOMETRY EVALUATION OF THE EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN PATIENTS AFFECTED BY INEFFECTIVE ESOPHAGEAL MOTILITY 60
Totale 7.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.781 0 151 16 79 208 329 351 270 43 124 203 7
2020/2021983 163 3 182 17 82 227 18 23 30 135 21 82
2021/2022789 35 15 4 200 46 16 24 66 54 9 88 232
2022/20232.154 188 207 108 264 194 488 145 158 253 41 59 49
2023/20241.002 79 51 62 36 34 292 236 37 14 44 19 98
2024/2025190 182 8 0 0 0 0 0 0 0 0 0 0
Totale 11.183